Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glycine receptor (GlyR) is a pentameric ligand-gated ion channel that mediates fast inhibitory neurotransmission, primarily in the central nervous system. It is a member of the Cys-loop superfamily of ligand-gated ion channels and plays a crucial role in motor coordination, regulation of respiration rhythm, pain signaling, and other higher brain functions. GlyRs mediate fast inhibitory transmission by allowing chloride ions to flow into neurons upon activation by glycine, causing hyperpolarization and reducing neuronal excitability. Alterations or mutations in glycine receptor genes or their trafficking can lead to neurological disorders such as hyperekplexia and epilepsy.
Binding of agonists like glycine opens the chloride channel, leading to hyperpolarization of the neuron and reduced excitability. Antagonists like strychnine competitively block glycine binding, preventing channel opening. Allosteric modulators can enhance or inhibit channel activity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine Receptor (GlyR).